Related Experiment Video
Updated: Nov 5, 2025
11:22
Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene Sequencing
Published on: October 15, 2019
30.5K
Gut microbiome research in multiple sclerosis.
Daiki Takewaki1, Takashi Yamamura1
1Department of Immunology, National Institute of Neuroscience, National Center of Neurology and Psychiatry, Japan; Multiple Sclerosis Center, National Center of Neurology and Psychiatry, Japan.
Neuroscience Research
|May 14, 2021
Summary
The gut microbiome influences multiple sclerosis (MS) development and progression. Analyzing this gut-brain axis connection offers new therapeutic strategies for MS and potentially a future cure.
Area of Science:
- Microbiome Science
- Neuroimmunology
- Gut-Brain Axis Research
Background:
- Specific gut microbial species are increasingly linked to human diseases.
- The gut-brain axis is a critical area of research in microbiome science.
- Multiple sclerosis (MS) and its animal model, experimental autoimmune encephalomyelitis, are actively studied.
- A bidirectional relationship between MS and the gut microbiome has been established.
Purpose of the Study:
- To elucidate the mechanisms by which the gut microbiome influences MS onset and progression.
- To explore the causal relationship between MS and gut microbial alterations.
- To identify novel therapeutic strategies for MS based on microbiome modulation.
Main Methods:
- Analysis of gut microbial species and their metabolites.
- Investigation of gut-associated oxidative stress in neurodegeneration.
- Studies on the mouse model of MS (experimental autoimmune encephalomyelitis).
Main Results:
- Reduced levels of short-chain fatty acids derived from the gut microbiome.
- Enrichment of gut-associated oxidative stress contributing to neurodegeneration.
- Evidence supporting a causal link between gut microbiome composition and MS.
Conclusions:
- The gut microbiome plays a significant role in the pathogenesis of MS.
- Understanding the gut microbiome offers a promising avenue for MS treatment and prevention.
- Targeting the gut microbiome could lead to novel therapeutic strategies and potentially a cure for MS.
